# Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome

> **NCT07540351** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing Daxing District Hospital of Integrated Chinese and Western Medicine** · enrollment: 188 (estimated)

## Conditions studied

- Allergic Rhinitis With Asthma

## Interventions

- **DRUG:** Yiqi Wenyang Sanhan Formula Combined with Acupoint Application
- **DRUG:** placebo of Yiqi Wenyang Sanhan Formula combined with acupoint application

## Key facts

- **NCT ID:** NCT07540351
- **Lead sponsor:** Beijing Daxing District Hospital of Integrated Chinese and Western Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07540351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07540351, "Efficacy and Safety of Yiqi Wenyang Sanhan Formula Combined With Acupoint Application in Patients With Combined Allergic Rhinitis and Asthma Syndrome During Remission and Yang-Deficiency Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07540351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*